Last updated: 2026-09-09 05:11:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Canopy Growth Corporation (CGC) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $0.97, with a market capitalization of $437.03M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.84 to $2.38. This page covers its latest market performance, valuation, price trends and company information.
$437.03M | |
$0.97 | |
$592.50 | |
$0.77 | |
$0.97 | |
2.19M | |
4.05M | |
-- | |
$2.38 | |
$0.84 | |
-- | |
-- |
Canopy Growth Corporation (CGC) last closed at $0.97 as of 2026-09-08 23:57:00, unchanged from the previous close of $0.97.
During the latest regular trading session, CGC traded between $0.77 and $592.50, with a volume of 2.19M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Canopy Growth Corporation (CGC) moved from $1.01 to $0.97, representing a decline of 4.36% ($0.04).
The stock traded between $0.96 and $1.04 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 2.38 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 8.0%
CGC is currently trading at $0.97, placing it 8.0% of the way from its 52-week low of $0.84 to its 52-week high of $2.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 1128 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Canopy Growth Corporation (CGC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.